The Stephan Co Stock EBITDA
The Stephan Co fundamentals help investors to digest information that contributes to Stephan's financial success or failures. It also enables traders to predict the movement of Stephan Pink Sheet. The fundamental analysis module provides a way to measure Stephan's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Stephan pink sheet.
Stephan |
The Stephan Co Company EBITDA Analysis
Stephan's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Stephan EBITDA | (9.19 M) |
Most of Stephan's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, The Stephan Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, The Stephan Co reported earnings before interest,tax, depreciation and amortization of (9.19 Million). This is 100.61% lower than that of the Personal Products sector and 100.38% lower than that of the Consumer Staples industry. The ebitda for all United States stocks is 100.24% higher than that of the company.
Stephan EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Stephan's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Stephan could also be used in its relative valuation, which is a method of valuing Stephan by comparing valuation metrics of similar companies.Stephan is currently under evaluation in ebitda category among its peers.
Stephan Fundamentals
| Return On Equity | -0.82 | |||
| Return On Asset | -0.3 | |||
| Profit Margin | (0.92) % | |||
| Operating Margin | (0.60) % | |||
| Current Valuation | 6.51 M | |||
| Shares Outstanding | 3.8 M | |||
| Shares Owned By Institutions | 0.02 % | |||
| Price To Earning | (0.62) X | |||
| Price To Book | 2.18 X | |||
| Price To Sales | 0.43 X | |||
| Revenue | 7.93 M | |||
| Gross Profit | (1.07 M) | |||
| EBITDA | (9.19 M) | |||
| Net Income | 655 K | |||
| Cash And Equivalents | 3.65 M | |||
| Cash Per Share | 0.90 X | |||
| Total Debt | 118 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 4.17 X | |||
| Book Value Per Share | 2.56 X | |||
| Cash Flow From Operations | 573 K | |||
| Earnings Per Share | (3.56) X | |||
| Number Of Employees | 95 | |||
| Beta | 0.33 | |||
| Market Capitalization | 6.97 M | |||
| Total Asset | 3.97 M | |||
| Retained Earnings | (14.39 M) | |||
| Working Capital | 1.49 M | |||
| Current Asset | 1.89 M | |||
| Current Liabilities | 407 K | |||
| Z Score | 25.6 | |||
| Annual Yield | 0.17 % | |||
| Net Asset | 3.97 M | |||
| Last Dividend Paid | 0.04 |
Pair Trading with Stephan
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Stephan position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stephan will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Pfizer could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pfizer when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pfizer - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pfizer Inc to buy it.
The correlation of Pfizer is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pfizer moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pfizer Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pfizer can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Stephan Pink Sheet
If you are still planning to invest in The Stephan check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Stephan's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |